Media Resources


Statement to INB/IHR Plenary Session

Statement to the Fifth Meeting of the Intergovernmental Negotiating Body

Statement to WHA76 – UHC

Statement to WHA76 – Health Emergencies

Joint Statement on the Impact of Artificial Intelligence on Health Outcomes for Key Populations: Navigating Health Inequalities in the EU

Statement to US International Trade Commission Public Hearing on COVID-19

WHO EURO Access to Novel Medicines Platform

Statement following latest session of the European Parliament’s COVI Committee

Statement to the Fourth Meeting of the Intergovernmental Negotiating Body – Consideration and Negotiation of the Zero Draft of the WHO Convention

Statement to the 152nd WHO Executive Board – Falsified and Substandard Medicines

Lack of diagnostic use hampering fight against antimicrobial resistance


Statement to WHO Euro RC72

HAI and Partners Launch SHARP Project

HAI Statement on Tentative Agreement on TRIPS and COVID-19

Statement to EB150: Global Strategy & Plan of Action

Statement to EB150: Pandemic Preparedness and Response


Statement on Pandemic Prevention, Preparedness and Response

Spanish Research Institute Licence with C-TAP

Oproep aan Nederlandse regering: toon politieke daadkracht tijdens topconferenties en promoot eerlijke toegang tot Covid-19 vaccins

Letter to the President of the European Council: European Council Meeting 20-21 October and TRIPS Waiver

New study estimates over nine million people living with type 1 diabetes

Analogue Insulin on WHO Model List of Essential Medicines

MEPs can deliver strong message to Commission on TRIPS waiver

WHO Members States must not miss opportunity to improve lives of over 460 million people with diabetes

Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines

HAI Statement on the Oslo Medicines Initiative


Health Action International Statement on the European Commission Pharmaceutical Strategy

HAI Statement to the 73rd WHA on public health, innovation and IP

HAI Statement to the WHO Executive Board – COVID-19

HAI Statement on Improving Access to Insulin